PDCD1 and tauopathy: With regard to the tauopathy study, Swartz and colleagues administered the same PD-1 antibody as in their Aβ model study to tauopathy mice at 8 months of age (a single intraperitoneal injection of 0.5 mg; Rosenzweig et al., 2019).